Publication | Closed Access

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

Cell TherapyGraft-versus-host DiseaseTransplantationMarrow TransplantationAutoimmune DiseaseBone Marrow FailureStem Cell TransplantationHematologyImmunologyPathologyAutoimmunityHematological MalignanciesImmunotherapyMedicineCell TransplantationGraft RejectionAnti-cd25 Monoclonal Antibody